120 results on '"Morrow, Charles S."'
Search Results
2. Data from Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin
3. Supplementary Figure Legends from Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin
4. Drug Resistance and Cancer
5. Modulation of nitrated lipid signaling by multidrug resistance protein 1 (MRP1): Glutathione conjugation and MRP1-mediated efflux inhibit nitrolinoleic acid-induced, PPArgamma-dependent transcription activation
6. Dynamics of glutathione conjugation and conjugate efflux in detoxification of the carcinogen, 4-nitroquinoline 1-oxide: Contributions of glutathione, glutathione S-transferase, and MRP1
7. Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane
8. Protective Efficacy of hGSTM1-1 against B[a]P and (+)- or (−)-B[a]P-7,8-Dihydrodiol Cytotoxicity, Mutagenicity, and Macromolecular Adducts in V79 Cells Coexpressing hCYP1A1
9. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1
10. Turning Chemopreventive Agents Against Breast Cancer: Sensitizing Cancers to Therapeutics While Protecting Normal Tissues from Toxicity
11. Detoxification of 1-Chloro-2,4-dinitrobenzene in MCF7 Breast Cancer Cells Expressing Glutathione S-Transferase P1-1 and/or Multidrug Resistance Protein 1
12. Noncatalytic interactions between glutathione S-transferases and nitroalkene fatty acids modulate nitroalkene-mediated activation of peroxisomal proliferator-activated receptor [gamma]
13. Differential potencies of naturally occurring regioisomers of nitrolinoleic acid in PPAR[gamma] activation
14. Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta(super 12,14) prostaglandin J2 (15-d-PGJ2)
15. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-delta(sup)12,14prostaglandin J(sub)2 in MCF7 breast cancer cells
16. Turning Chemopreventive Agents Against Breast Cancer: Sensitizing Cancers to Therapeutics While Protecting Normal Tissues from Toxicity
17. Nitric Oxide Storage and Transport in Cells Are Mediated by Glutathione S-Transferase P1-1 and Multidrug Resistance Protein 1 via Dinitrosyl Iron Complexes
18. Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1)
19. Nitroalkene Fatty Acids Mediate Activation of Nrf2/ARE-Dependent and PPARγ-Dependent Transcription by Distinct Signaling Pathways and with Significantly Different Potencies
20. Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) by Nitroalkene Fatty Acids: Importance of Nitration Position and Degree of Unsaturation
21. Differential protection by human glutathione S-transferase P1 against cytotoxicity of benzo[a]pyrene, dibenzo[a,l]pyrene, or their dihydrodiol metabolites, in bi-transgenic cell lines that co-express rat versus human cytochrome P4501A1
22. Noncatalytic Interactions between Glutathione S-Transferases and Nitroalkene Fatty Acids Modulate Nitroalkene-Mediated Activation of Peroxisomal Proliferator-Activated Receptor γ
23. Differential Potencies of Naturally Occurring Regioisomers of Nitrolinoleic Acid in PPARγ Activation
24. Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin
25. Cytotoxicity and mutagenicity of dibenzo[a,l]pyrene and (±)-dibenzo[a,l]pyrene-11,12-dihydrodiol in V79MZ cells co-expressing either hCYP1A1 or hCYP1B1 together with human glutathione-S-transferase A1
26. Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediates Resistance to Mitoxantrone via Glutathione-Dependent Drug Efflux
27. 5-Oxo-ETE analogs and the proliferation of cancer cells
28. CANCER CHEMOTHERAPY AND DRUG METABOLISM
29. Dynamics of Glutathione Conjugation and Conjugate Efflux in Detoxification of the Carcinogen, 4-Nitroquinoline 1-Oxide: Contributions of Glutathione, GlutathioneS-Transferase, and MRP1†
30. Glutathione S-Transferases (GSTs) Inhibit Transcriptional Activation by the Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Ligand, 15-Deoxy-Δ12,14Prostaglandin J2 (15-d-PGJ2)
31. Role of Multidrug Resistance Protein 2 (MRP2, ABCC2) in Alkylating Agent Detoxification: MRP2 Potentiates GlutathioneS-Transferase A1-1-Mediated Resistance to Chlorambucil Cytotoxicity
32. Multidrug Resistance Protein (MRP) 1 and MRP3 Attenuate Cytotoxic and Transactivating Effects of the Cyclopentenone Prostaglandin, 15-Deoxy-Δ12,14Prostaglandin J2 in MCF7 Breast Cancer Cells
33. Modeling the metabolic competency of glutathione S-transferases using genetically modified cell lines
34. Role of Multidrug Resistance Protein 1 (MRP1) and Glutathione S-Transferase A1-1 in Alkylating Agent Resistance
35. Coordinate Transcriptional and Translational Regulation of Ferritin in Response to Oxidative Stress
36. Role of multidrug-resistance protein 2 in glutathioneS-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells
37. MODELING THE CHEMOPROTECTIVE FUNCTIONS OF GLUTATHIONE S-TRANSFERASES IN CULTURED CELL LINES BY HETEROLOGOUS EXPRESSION*
38. Combined expression of multidrug resistance protein (MRP) and glutathione S-transferase P1-1 (GSTP1-1) in MCF7 cells and high level resistance to the cytotoxicities of ethacrynic acid but not oxazaphosphorines or cisplatin
39. Overexpression of Stably Transfected Human GlutathioneS-Transferase P1–1 Protects against DNA Damage by Benzo[a]pyrene Diol-Epoxide in Human T47D Cells
40. Coordinated Action of Glutathione S-Transferases (GSTs) and Multidrug Resistance Protein 1 (MRP1) in Antineoplastic Drug Detoxification
41. Chemoprotective functions of glutathione S-transferases in cell lines induced to express specific isozymes by stable transfection1Presented by A.J. Townsend at The International Conference on Glutathione and Glutathione-Linked Enzymes in Human Cancer and Other Diseases, Oct. 31–Nov. 3, 1996 at Hilton Head, S.C.1
42. Contribution of proximal promoter elements to the regulation of basal and differential glutathione S-transferase P1 gene expression in human breast cancer cells
43. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells
44. Role of Posttranscriptional Processes in the Regulation of GlutathioneS-Transferase P1 Gene Expression in Human Breast Cancer Cells
45. Markedly Decreased Expression of Glutathione S-Transferase π Gene in Human Cancer Cell Lines Resistant to Buthionine Sulfoximine, an Inhibitor of Cellular Glutathione Synthesis
46. Antineoplastic Drug Resistance and Breast Cancer
47. Selenium-Dependent Glutathione Peroxidase Expression is Inversely Related to Estrogen Receptor Content of Human Breast Cancer Cells
48. Regulation of human glutathione S-transferase π gene transcription: influence of 5′-flanking sequences and trans-mactivating factors which recognize AP-1-binding sites
49. Dynamics of Glutathione Conjugation and Conjugate Efflux in Detoxification of the Carcinogen, 4-Nitroquinoline 1-Oxide: Contributions of Glutathione, Glutathione S-Transferase, and MRP1.
50. Multidrug Resistance Protein (MRP) 1 and MRP3 Attenuate Cytotoxic and Transactivating Effects of the Cyclopentenone Prostaglandin, 15-Deoxy-Δ[sup 12,14] Prostaglandin J[sub 2] in MCF7 Breast Cancer Cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.